Breast Cancer Double Marker, IHC
Test Overview
Breast Cancer Double Marker by Immunohistochemistry (IHC) is used to evaluate the expression of specific tumor markers in breast tissue samples. This test helps pathologists classify breast cancer types, assess tumor characteristics, and support treatment planning.
Why This Test is Done
- To identify important breast cancer markers
- To assist in diagnosis and tumor classification
- To support prognosis and treatment decisions
- To evaluate hormone receptor or protein expression in tumor tissue
Sample Required
- Formalin-fixed paraffin-embedded (FFPE) tissue block/slides
Method
- Immunohistochemistry (IHC)
Benefits
- Accurate tumor marker detection
- Helps guide personalized therapy
- Supports oncologists in treatment planning
- Useful in breast cancer evaluation and monitoring
Recommended For
- Patients with suspected or confirmed breast cancer
- Histopathological evaluation of breast tissue
- Oncologists and surgeons for treatment assessment
Reporting Time
- As per laboratory protocol
Preparation
- No special preparation required
Note
Test interpretation should always be correlated with clinical findings and histopathology results.
